Cardiac MR spectroscopy in the new millennium

Area of Science:

• Cardiovascular Imaging
• Biomedical Spectroscopy
• Clinical Diagnostics

Background:

• Cardiovascular diseases necessitate comprehensive heart evaluation, including morphology, function, and metabolism.
• Phosphorus-31 Nuclear Magnetic Resonance (31P-NMR) spectroscopy is a key noninvasive tool for assessing myocardial energy metabolism.
• Altered phosphocreatine (PCr) to Adenosine Triphosphate (ATP) ratios indicate metabolic dysfunction in conditions like ischemic heart disease, heart failure, and cardiomyopathies.

Purpose of the Study:

• To highlight the integral role of spectroscopy in clinical cardiac Magnetic Resonance (MR) examinations.
• To demonstrate the utility of 31P-NMR spectroscopy in evaluating myocardial energy metabolism and viability.
• To discuss the potential of advanced NMR techniques for improved clinical cardiac assessment.

Main Methods:

• Utilizing 31P-NMR spectroscopy to noninvasively measure myocardial energy metabolism at rest and during stress.
• Analyzing NMR spectra to assess intracellular creatine, myocardial lipids, and sodium (23Na) concentrations.
• Leveraging advancements in magnetic field strength, gradient capabilities, and pulse sequences for enhanced resolution.

Main Results:

• Abnormalities in the PCr/ATP ratio are indicative of various cardiac pathologies.
• NMR spectroscopy can detect early metabolic changes associated with myocardial ischemia.
• Increased total 23Na in ischemic tissue correlates with the extent and location of viable tissue.

Conclusions:

• Spectroscopy is poised to become essential for complete cardiac evaluation, providing metabolic insights.
• 31P-NMR spectroscopy aids in assessing myocardial viability and detecting metabolic alterations in heart disease.
• Technological advancements in NMR will further enhance its clinical utility in cardiology.